Stonepine Capital Management, LLC - 29 Oct 2025 SCHEDULE 13G Report for CNS Pharmaceuticals, Inc. Common Stock (CNSP)

Filing Manager
Stonepine Capital Management, LLC
Reporting Manager
Stonepine Capital Management, LLC
Security
CNS Pharmaceuticals, Inc. Common Stock
Symbol
CNSP
Shares outstanding
575,357 shares
Disclosed Ownership
32,220 shares
Ownership
5.6%
Form type
SCHEDULE 13G
Filing time
04 Nov 2025, 12:19:18 UTC
Date of event
29 Oct 2025
Next filing
13 Feb 2026
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Stonepine Capital Management, LLC 5.6% 32,220 0 32,220 /s/ Jon M. Plexico Managing Member
Stonepine Capital, L.P. 5.6% 32,220 0 32,220 /s/ Jon M. Plexico Managing Member of the General Partner, Stonepine GP, LLC
Stonepine GP, LLC 5.6% 32,220 0 32,220 /s/ Jon M. Plexico Managing Member
Jon M. Plexico 5.6% 32,220 0 32,220 /s/ Jon M. Plexico Reporting person